Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

July 15, 2025

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

October 24, 2023

Top Endovascular News of 2022

News Daily News

Top Endovascular News of 2022

January 03, 2023

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

November 03, 2022

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

June 01, 2022

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

April 22, 2021

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

October 09, 2020

Recovered Paclitaxel PAD Data Shift the Mortality Picture

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

May 14, 2020

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

June 10, 2019

TCTMD’s Top 10 Most Popular Stories for February 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

March 01, 2019

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

December 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.